Updated: 5:35 PM EST Dec 28, 2020 A new study shows the HPV vaccine is curbing cervical cancer risk.The study published in the New England Journal of Medicine found there is a significant decrease in cervical cancer patients who have received the HPV vaccine compared to those who did not.The vaccine was developed in 2006. Mercy Medical Center s Dr. Beman Khulpateea said the study finally puts together years of data. One of the things the study pointed out was the benefit of early vaccination, so people who get a vaccine at an early age both girls and boys have a lower risk of developing subsequent disease, Khulpateea said.In the United States, doctors recommend starting HPV vaccinations at 11 or 12 years old.